Lithium

Lithium

SCHEMBL5199989

CC(Nc1ccccc1)C1=CCC=C1.[Li].[Li]

nearest known ligand 0.45

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 2/20 0.45
▸ GAA P10253 1/20 0.43
▸ ALDH1A1 P00352 5/20 0.41
▸ TSHR P16473 3/20 0.40
▸ LMNA P02545 3/20 0.40
▸ CYP3A4 P08684 2/20 0.40
▸ ALOX15 P16050 2/20 0.40
▸ ALOX12 P18054 2/20 0.40
▸ HSD17B10 Q99714 2/20 0.40
▸ THRB P10828 1/20 0.40
▸ RECQL P46063 1/20 0.40
▸ ATM Q13315 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ MAPK1 P28482 1/20 0.39
▸ HIF1A Q16665 1/20 0.39
▸ MEN1 O00255 2/20 0.37
▸ KMT2A Q03164 2/20 0.37
▸ VDR P11473 1/20 0.37
▸ NPSR1 Q6W5P4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6376702 0.68 GAA (0.73) TDP1GAAALDH1A1TSHRLMNA
SCHEMBL5604987 0.68 GAA (0.73) TDP1GAAALDH1A1TSHRLMNA
SCHEMBL10054998 0.68 GAA (0.73) TDP1GAAALDH1A1TSHRLMNA
SCHEMBL1884341 0.68 GAA (0.73) TDP1GAAALDH1A1TSHRLMNA
SCHEMBL27547071 0.66 GAA (0.70) TDP1GAAALDH1A1TSHRLMNA
SCHEMBL18416413 0.64 TDP1 (0.50) TDP1GAAALDH1A1TSHRLMNA
SCHEMBL990038 0.64 TDP1 (0.70) TDP1GAAALDH1A1TSHRLMNA
SCHEMBL841689 0.64 TDP1 (0.70) TDP1GAAALDH1A1TSHRLMNA
SCHEMBL66892 0.64 TDP1 (1.00) TDP1GAAALDH1A1TSHRLMNA
SCHEMBL6242838 0.63 TDP1 (0.61) TDP1GAAALDH1A1TSHRLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1284981-B1 METHOD FOR PRODUCING TRANSITION METAL COMPOUNDS AND THEIR USE FOR THE POLYMERIZATION OF OLEFINS BASELL POLYOLEFINE GMBH (DE) 2007-07-11 — — EP disclosed
US-7105690-B2 Method for producing transition metal compounds and their use for the polymerization of olefins BASELL POLYOLEFINE GMBH (DE) 2006-09-12 — — US disclosed
US-20030191334-A1 Method for producing transition metal compounds and their use for the polymerization of olefins BASELL POLYPROPYLEN GMBH (DE) 2003-10-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030191334-A1 Method for producing transition metal compounds and their use for the polymerization of olefins PPOX, PORCN, FASN TDP1 4123/4885GAA 3341/4885ALDH1A1 1760/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback